Enkephalin and dynorphin mRNA expression are associated with resilience or vulnerability to chronic social defeat stress

Physiology and Behavior

Volumn 122, Issue , 2013, Pages 237-245

  Bérubé, Patrick ^a   Laforest, Sylvie ^a   Bhatnagar, Seema ^b   Drolet, Guy ^a  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Accumbens; Amygdala; Coping; Endorphin; Opioids

Indexed keywords

DYNORPHIN; ENKEPHALIN; MESSENGER RNA;

ADAPTATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTERIOR CINGULATE; ANXIETY; ARTICLE; BASOLATERAL AMYGDALA; BEHAVIOR; CHRONIC SOCIAL DEFEAT STRESS; CHRONIC STRESS; CONTROLLED STUDY; COPING BEHAVIOR; CORPUS STRIATUM; FOREBRAIN; GENE EXPRESSION; INSULA; LATENT PERIOD; MALE; NEUROTRANSMISSION; NONHUMAN; NUCLEUS ACCUMBENS; ORBITAL CORTEX; PREFRONTAL CORTEX; PRIORITY JOURNAL; PYRIFORM CORTEX; RAT; SOCIAL STRESS; VULNERABILITY;

ACCUMBENS; AMYGDALA; COPING; ENDORPHIN; OPIOIDS;

ADAPTATION, PSYCHOLOGICAL; AMYGDALA; ANIMALS; DYNORPHINS; ENKEPHALINS; MALE; RATS; RATS, SPRAGUE-DAWLEY; RESILIENCE, PSYCHOLOGICAL; RNA, MESSENGER; STRESS, PSYCHOLOGICAL;

EID: 84888057259     PISSN: 00319384     EISSN: 1873507X     Source Type: Journal    
DOI: 10.1016/j.physbeh.2013.04.009     Document Type: Article

References (42)

1. Charney D.S. Psychobiological mechanisms of resilience and vulnerability: implications for successful adaptation to extreme stress. Am J Psychiatry 2004, 161:195-216.
2. Amat J., Baratta M.V., Paul E., Bland S.T., Watkins L.R., Maier S.F. Medial prefrontal cortex determines how stressor controllability affects behavior and dorsal raphe nucleus. Nat Neurosci 2005, 8:365-371.
3. Krishnan V., Han M.H., Graham D.L., Berton O., Renthal W., Russo S.J., et al. Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell 2007, 131:391-404.
4. Sajdyk T.J., Johnson P.L., Leitermann R.J., Fitz S.D., Dietrich A., Morin M., et al. Neuropeptide Y in the amygdala induces long-term resilience to stress-induced reductions in social responses but not hypothalamic-adrenal-pituitary axis activity or hyperthermia. J Neurosci 2008, 28:893-903.
5. Kang W., Wilson S.P., Wilson M.A. Overexpression of proenkephalin in the amygdala potentiates the anxiolytic effects of benzodiazepines. Neuropsychopharmacology 2000, 22:77-88.
6. Drolet G., Dumont E.C., Gosselin I., Kinkead R., Laforest S., Trottier J.F. Role of endogenous opioid system in the regulation of the stress response. Prog Neuropsychopharmacol Biol Psychiatry 2001, 25:729-741.
7. Hebb A., Zacharko R.M., Gauthier M., Trudel F., Laforest S., Drolet G. Brief exposure to predator odor and resultant anxiety enhances mesocorticolimbic activity and enkephalin expression in CD-1 mice. Eur J Neurosci 2004, 20:2415-2429.
8. Hebb A., Drolet G., Mendella P., Roach S., Gauthier M., Zacharko R. Intracerebroventricular d-Pen2, d-Pen5-enkephalin administration soon after stressor imposition influences behavioral responsivity to a subsequent stressor encounter in CD-1 mice. Pharmacol Biochem Behav 2005, 82:453-469.
9. Hebb A., Poulin J., Roach S., Zacharko R., Drolet G. Cholecystokinin and endogenous opioid peptides: interactive influence on pain, cognition, and emotion. Prog Neuropsychopharmacol Biol Psychiatry 2005, 29:1225-1238.
10. Filliol D., Ghozland S., Chluba J., Martin M., Matthes H.W., Simonin F., et al. Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses. Nat Genet 2000, 25:195-200.
11. König M., Zimmer A.M., Steiner H., Holmes P.V., Crawley J.N., Brownstein M.J., et al. Pain responses, anxiety and aggression in mice deficient in pre-proenkephalin. Nature 1996, 383:535-538.
12. Ragnauth A., Schuller A., Morgan M., Chan J., Ogawa S., Pintar J., et al. Female preproenkephalin-knockout mice display altered emotional responses. Proc Natl Acad Sci U S A 2001, 98:1958-1963.
13. McLaughlin J.P., Marton-Popovici M., Chavkin C. Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses. J Neurosci 2003, 23:5674-5683.
14. Mague S.D. Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats. J Pharmacol Exp Ther 2003, 305:323-330.
15. Beardsley P.M., Howard J.L., Shelton K.L., Carroll F.I. Differential effects of the novel kappa opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats. Psychopharmacology 2005, 183:118-126.
16. Carlezon W.A. Depressive-like effects of the kappa-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats. J Pharmacol Exp Ther 2005, 316:440-447.
17. Carey A., Borozny K., Aldrich J., McLaughlin J. Reinstatement of cocaine place-conditioning prevented by the peptide kappa-opioid receptor antagonist arodyn. Eur J Pharmacol 2007, 569:84-89.
18. Bruchas M.R., Land B.B., Aita M., Xu M., Barot S.K., Li S., et al. Stress-induced p38 mitogen-activated protein kinase activation mediates kappa-opioid-dependent dysphoria. J Neurosci 2007, 27:11614-11623.
19. Shippenberg T., Zapata A., Chefer V. Dynorphin and the pathophysiology of drug addiction. Pharmacol Ther 2007, 116:306-321.
20. Land B.B., Bruchas M.R., Lemos J.C., Xu M., Melief E.J., Chavkin C. The dysphoric component of stress is encoded by activation of the dynorphin -opioid system. J Neurosci 2008, 28:407-414.
21. Bruchas M.R., Land B.B., Lemos J.C., Chavkin C. CRF1-R activation of the dynorphin/kappa opioid system in the mouse basolateral amygdala mediates anxiety-like behavior. PLoS One 2009, 4:e8528.
22. Wood S.K., Walker H.E., Valentino R.J., Bhatnagar S. Individual differences in reactivity to social stress predict susceptibility and resilience to a depressive phenotype: role of corticotropin-releasing factor. Endocrinology 2010, 151:1795-1805.
23. Wood S.K., McFadden K.V., Grigoriadis D., Bhatnagar S., Valentino R.J. Depressive and cardiovascular disease comorbidity in a rat model of social defeat: a putative role for corticotropin-releasing factor. Psychopharmacology 2012, 222:325-336.
24. Wood S.K., Baez M.A., Bhatnagar S., Valentino R.J. Social stress-induces blader dysfunction: potential role of corticotropin-releasing factor. Am J Physiol Regul Integr Comp Physiol 2009, 296:1671-1678.
25. Komatsu H., Ohara A., Sasaki K., Abe H., Hattori H., Hall F.S., et al. Decreased response to social defeat stress in μ-opioid-receptor knockout mice. Pharmacol Biochem Behav 2011, 99:676-682.
26. McDonald A.J. Topographical organization of amygdaloid projections to the caudatoputamen, nucleus accumbens, and related striatal-like areas of the rat brain. NSC 1991, 44:15-33.
27. Shinonaga Y., Takada M., Mizuno N. Topographic organization of collateral projections from the basolateral amygdaloid nucleus to both the prefrontal cortex and nucleus accumbens in the rat. NSC 1994, 58:389-397.
28. Pitkänen A., Savander V., LeDoux J.E. Organization of intra-amygdaloid circuitries in the rat: an emerging framework for understanding functions of the amygdala. Trends Neurosci 1997, 20:517-523.
29. McDonald A.J. Projection neurons of the basolateral amygdala: a correlative Golgi and retrograde tract tracing study. Brain Res Bull 1992, 28:179-185.
30. Poulin J.F., Castonguay-Lebel Z., Laforest S., Drolet G. Enkephalin co-expression with classic neurotransmitters in the amygdaloid complex of the rat. J Comp Neurol 2008, 506:943-959.
31. McLaughlin J.P., Li S., Valdez J., Chavkin T.A., Chavkin C. Social defeat stress-induced behavioral responses are mediated by the endogenous kappa opioid system. Neuropsychopharmacology 2006, 31:1241-1248.
32. Grimwood S., Lu Y., Schmidt A.W., Vanase-Frawley M.A., Sawant-Basak A., Miller E., et al. Pharmacological characterization of 2-methyl-N-((2'-(pyrrolidin-1-ylsulfonyl)biphenyl-4-yl)methyl) propan-1-amine (PF-04455242), a high-affinity antagonist selective for κ-opioid receptors. J Pharmacol Exp Ther 2011, 339:555-566.
33. Reynolds S.M., Berridge K.C. Emotional environments retune the valence of appetitive versus fearful functions in nucleus accumbens. Nat Neurosci 2008, 11:423-425.
34. Kalivas P.W., Duffy P. Selective activation of dopamine transmission in the shell of the nucleus accumbens by stress. Brain Res 1995, 675:325-328.
35. Newton S.S., Thome J., Wallace T.L., Shirayama Y., Schlesinger L., Sakai N., et al. Inhibition of cAMP response element-binding protein or dynorphin in the nucleus accumbens produces an antidepressant-like effect. J Neurosci 2002, 22:10883-10890.
36. Devan B.D., Hong N.S., McDonald R.J. Parallel associative processing in the dorsal striatum: segregation of stimulus-response and cognitive control subregions. Neurobiol Learn Mem 2011, 96:95-120.
37. Yin H.H., Ostlund S.B., Balleine B.W. Reward-guided learning beyond dopamine in the nucleus accumbens: the integrative functions of cortico-basal ganglia networks. Eur J Neurosci 2008, 28:1437-1448.
38. Ragsdale C.W., Graybiel A.M. The fronto-striatal projection in the cat and monkey and its relationship to inhomogeneities established by acetylcholinesterase histochemistry. Brain Res 1981, 208:259-266.
39. Ragozzino M.E., Ragozzino K.E., Mizumori S.J.Y., Kesner R.P. Role of the dorsomedial striatum in behavioral flexibility for response and visual cue discrimination learning. Behav Neurosci 2002, 116:105-115.
40. Balleine B.W., Doherty J.P.O.A. Human and rodent homologies in action control: corticostriatal determinants of goal-directed and habitual action. Neuropsychopharmacology 2009, 35:48-69.
41. Ragsdale C.W., Graybiel A.M. Fibers from the basolateral nucleus of the amygdala selectively innervate striosomes in the caudate nucleus of the cat. J Comp Neurol 1988, 269:506-522.
42. Swanson L.W. Brain maps III: structure of the rat brain 2003, Elsevier Science & Technology Books.